Home > Insider Trading > Filing (0001209191-17-065191)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1267565	Collegium Pharmaceutical Inc	COLL	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1253886	G Patrick Enright	2740 Sand Hill Road, 2Nd Floor Menlo Park CA 94025	No	No	Yes	No
1419701	L.p. Partners Venture Longitude	2740 Sand Hill Road, 2Nd Floor Menlo Park CA 94025	No	No	Yes	No
1430719	Longitude Capital Associates, L.p.	2740 Sand Hill Road, 2Nd Floor Menlo Park CA 94025	No	No	Yes	No
1430720	Longitude Capital Partners, Llc	2740 Sand Hill Road, 2Nd Floor Menlo Park CA 94025	No	No	Yes	No
1431159	Juliet Bakker Tammenoms	2740 Sand Hill Road, 2Nd Floor Menlo Park CA 94025	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-12-08	980,350	$17.34	2,276,222	No	4	S	Indirect	By LVP
Common Stock	Disposition	2017-12-08	19,650	$17.34	45,620	No	4	S	Indirect	By LCA

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By LVP
No	4	S	Indirect	By LCA

Footnotes

This report is filed jointly by Longitude Capital Partners, LLC ("LCP"), Longitude Venture Partners, L.P. ("LVP"), Longitude Capital Associates, L.P. ("LCA"), Patrick G. Enright ("Enright") and Juliet Tammenoms Bakker ("Bakker"). LCP is the general partner of LVP and LCA, has the power to vote and dispose of the securities of the Issuer held by each of LVP and LCA, and may be deemed to have beneficial ownership of such securities. Each of Enright and Bakker is a managing member of LCP, has the power to vote and dispose of the securities of the Issuer held by each of LVP and LCA, and may be deemed to have beneficial ownership of such securities. Each of LCP, Enright and Bakker disclaims beneficial ownership of the securities of the Issuer held by LVP and LCA except to the extent of their respective pecuniary interest therein.